MSB 2.51% 97.0¢ mesoblast limited

MESO action tonight, page-880

  1. 576 Posts.
    lightbulb Created with Sketch. 75
    Its ridiculous that Gilead is getting some so much coverage, if only Si could be interviewed on CNBC rather on the Eureka report, then the worlds perspective would change.We actually have a product that can prevent death which is everyone's fear.Im I surprised that MSB 's PR company has not been able to facilitate this with CNBC in Australia....maybe it will still happen , then watch Meso go.

    Still expecting a positive night for MESO.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.